Trademarkia Logo

Australia

AU$
VOXVOKA
Protected: Registered/protected

Last updated on 30 Nov 2023

Owner Info

Vertex Pharmaceuticals Incorporated

50 Northern Avenue

Boston MA 02210, UNITED STATES OF AMERICA

Serial Number

2235048 filed on 9 Nov 2021

Correspondent

Timothy H. Hiebert Womble Bond Dickinson (US) LLP

470 Atlantic Ave.,

Boston MA 02210-2228,

UNITED STATES OF AMERICA

VOXVOKA

Classification Information


Class [005]
Pharmaceutical preparations primarily comprising cells for the treatment of beta thalassemia and sickle cell disease.

Mark Details


Serial Number

2235048

Registered On

9 Nov 2021

Renewal On

9 Nov 2031

Mark Type

WORD

Priority Claim (Convention Details)


Date

28 Oct 2021

Mark Type

US

Legal History


Show more

Status DateAction Taken
30th Nov 2023IP Right Goods and Services Items updated
30th Nov 2023IP right goods and service classes updated
8th Jun 2022International Registration in Australia Protected correspondence sent
7th Jun 2022IP Right Registration Published
7th Jun 2022Status change to Registered/Protected
29th Mar 2022Application Accepted correspondence sent
29th Mar 2022IP Right has been Examined
29th Mar 2022IP Right Acceptance Published
15th Dec 2021Status change to Accepted
10th Dec 2021Awaiting examination